ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Search by Abstract Number Results

  • Abstract Number: 1918 • ACR Convergence 2024

    Exploring the Childhood Opportunity Index and Distance to Care in a Cohort of Children with Rheumatic Disease

    Kristina Ciaglia1 and Alaina Beauchamp2, 1UT Southwestern Medical Center and Scottish Rite for Children, Dallas, TX, 2UT Southwestern Medical Center, Dallas

    Background/Purpose: Children from disadvantaged neighborhoods and socioeconomic backgrounds experience worse outcomes and delays in care.¹ The Childhood Opportunity Index (COI) is a multidimensional validated tool…
  • Abstract Number: 1918 • ACR Convergence 2023

    Nationwide Analysis of Predictors of Sarcoid Inpatient Mortality

    Michael Manansala1, Faria Sami2, Shilpa Arora3 and Augustine Manadan1, 1Rush University Medical Center, Chicago, IL, 2John H. Stroger Jr. Hospital of Cook County, Chicago, IL, 3Cook County Hospital, Chicago, IL

    Background/Purpose: Sarcoidosis is multisystem autoimmune disease characterized by noncaseating granulomas which can result in significant morbidity and mortality. This study aims to identify variables associated…
  • Abstract Number: 1918 • ACR Convergence 2022

    Neurobiological Mechanisms of a Remote-Delivered Mind-body Intervention for Knee Osteoarthritis

    Jian Kong1 and Chenchen Wang2, 1Massachusetts General Hospital, Boston, MA, 2Tufts Medical Center, Boston, MA

    Background/Purpose: As a recommended intervention for knee Osteoarthritis (OA) according to current guidelines, Tai Chi, a multi-dimensional exercise has exhibited clinically significant improvements in knee…
  • Abstract Number: 1918 • ACR Convergence 2021

    Don’t Forget About the Arthritis in RA-ILD! Impact of Pulmonary and RA Disease Severity on Survival

    Rebecca Brooks1, Joshua Baker2, Yangyuna Yang1, Punyasha Roul1, Gail Kerr3, Andreas Reimold4, Gary Kunkel5, Katherine Wysham6, Namrata Singh7, Deana Lazaro8, Paul Monach9, Jill Poole1, Dana Ascherman10, Ted Mikuls1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3Washington D.C., Veterans Affairs Medical Center (VAMC)/Georgetown and Howard Universities, Washington, DC, 4University of Texas – Southwestern Medical Center/Dallas Veterans Affairs Medical Center (VAMC), Dallas, TX, 5University of Utah, Salt Lake City, UT, 6VA Puget Sound/University of Washington, Seattle, WA, 7University of Washington, Bellevue, WA, 8VA New York Harbor Healthcare system, Brooklyn, NY, 9Brigham and Women's Hospital, Boston, MA, 10University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Long-term outcomes following a diagnosis of rheumatoid arthritis associated interstitial lung disease (RA-ILD) are poor, with a median survival estimated between 3 to 8…
  • Abstract Number: 1918 • ACR Convergence 2020

    Efficacy and Safety of Methotrexate in Giant Cell Arteritis: Results from a Bicentric Portuguese Cohort Study

    Sofia Barreira1, Ana Rita Cruz-Machado2, Eduardo Dourado3, Joana Martinho2, Diana Raimundo4, Luísa Brites5, Helena Assunção5, Vítor Teixeira6, Nikita Khmelinskii2, Carla Macieira2, José A. P. da Silva7, João Eurico Fonseca8 and Cristina Ponte2, 1Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal, 2Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 3Rheumatology Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, Lisboa, Lisboa, Portugal, 4Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal, 5Rheumatology Department, Centro Hospitalar Universitário Coimbra, Coimbra, Portugal, 6Rheumatology Department, Centro Hospitalar Universitário do Algarve, Faro, Portugal, 79.Centro Hospitalar e Universitário Coimbra (Rheumatology Department), Coimbra, Portugal, Coimbra, Portugal, 8Instituto de Medicina Molecular, Faculdade Medicina Universidade de Lisboa and Centro Hospitalar Universitário Lisboa Norte., Lisboa, Portugal

    Background/Purpose: Giant Cell Arteritis (GCA) is a large- and medium-sized vessel vasculitis affecting patients >50 years-old. High-doses of glucocorticoids (GCs) should be initiated promptly to…
  • Abstract Number: 1918 • 2019 ACR/ARP Annual Meeting

    Urine CD163 Significantly Discriminates Active Lupus Nephritis and Strongly Correlates with Proliferative Glomerulonephritis

    Ting Zhang1, Ramesh Saxena 2, Chi Chiu Mok 3, Michelle Petri 4 and Chandra Mohan 5, 1Biomedical Engineering, University of Houston, Houston, TX, 2UTSW, Dallas, 3Department of Medicine, Tuen Mun Hospital, Hong Kong, China (People's Republic), 4Johns Hopkins University School of Medicine, Baltimore, MD, 5University of Houston, Houston

    Background/Purpose: CD163 is a marker for alternatively activated M2 macrophages, which have been implicated in the pathogenesis of lupus nephritis (LN). The potential of urine…
  • Abstract Number: 1918 • 2018 ACR/ARHP Annual Meeting

    Defining Pain That Does Not Interfere with Activities Among Rheumatoid Arthritis (RA) Patients

    Yvonne C. Lee1, Patricia Katz2,3, Amanda Quebe4, Luna Sun4, Himanshu Patel4, Carol L. Gaich4, Natalie Boytsov4 and Kaleb Michaud5,6, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2Forward/National Data Bank for Rheumatic Diseases, Wichita, KS, 3University of California San Francisco, San Francisco, CA, 4Eli Lilly and Company, Indianapolis, IN, 5Rheumatology, University of Nebraska Medical Center, Omaha, NE, 6FORWARD, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: RA patients differ in the degree to which pain interferes with function. To improve function, an understanding of this diversity is needed. Our objectives…
  • Abstract Number: 1918 • 2017 ACR/ARHP Annual Meeting

    Blood Levels of Complement Split Product iC3b and C3 Outperform Traditional Biochemical Measures of SLE Disease Activity in Associating with Active and Clinically Meaningful Changes

    Alfred Kim1, Deepali Sen2, Vibeke Strand3, Qiang John Fu4, Nancy Mathis1, Martin Schmidt5, Robin Bruchas6, Nick Staten6, Paul Olson6, Chad Stiening6 and John Atkinson1, 1Rheumatology, Washington University School of Medicine, Saint Louis, MO, 2Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, 3Stanford University, Palo Alto, CA, 4Biostatistics, Saint Louis University, Saint Louis, MO, 5Kypha, Inc., St. Louis, MO, 6Kypha, Inc., Saint Louis, MO

    Background/Purpose: A major unmet need in SLE is the identification of a biomarker that consistently tracks with disease activity. One current approach is measuring complement…
  • Abstract Number: 1918 • 2016 ACR/ARHP Annual Meeting

    Characterising the Specificity, Function and Behavior of CD4+ T Cells Initiating Inflammation in a Murine Model of Rheumatoid Arthritis

    Robert Benson1, Catriona Prendergast2, Iain B McInnes2, James Brewer3 and Paul Garside4, 1nstitute of Infection, Immunity & Inflammation, University of Glasgow, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom, 4University of Glasgow, Glasgow, Great Britain

    Background/Purpose: CD4+ T cells are important contributors to the pathogenesis of Rheumatoid Arthritis (RA). The presence of activated T cells in the inflamed synovium, strong…
  • Abstract Number: 1918 • 2015 ACR/ARHP Annual Meeting

    Pharmacologic Targeting of Mitochondrial Dysfunction in Systemic Sclerosis: Enhanced SIRT3 Signaling

    Kaname Akamata1, Mitra Bhattacharyya1, Mahesh Gupta2, Jack Arbiser3, David Kamp4, Jun Wei1 and John Varga1, 1Division of Rheumatology, Northwestern University, Feinberg School of Medicine, Chicago, IL, 2University of Chicago, Departments of Surgery, Chicago, IL, 3Department of Dermatology, Emory University School of Medicine Winship Cancer Institute Atlanta Veterans Administration Health Center, Atlanta, GA, 4Department of Medicine, Division of Pulmonary & Critical Care Medicine, Jesse Brown VA Medical Center and Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Recent evidences suggest that cytosolic and mitochondrial reactive oxygen species (ROS), play pivotal roles in modulating TGF-β-induced profibrotic responses and are implicated in pathogenesis…
  • Abstract Number: 1918 • 2014 ACR/ARHP Annual Meeting

    IL23 Overexpression Demonstrates Gut-Joint Inflammation Link and Increased Expression of Spondyloarthopathy Associated Genes In Vivo

    Donald Souza II, Immunology & Inflammation, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT

    Background/Purpose: It has been well established that a close relationship exists between gut inflammation and spondyloarthropathies. Polymorphisms in the receptor for IL23 are associated not…
  • Abstract Number: 1918 • 2013 ACR/ARHP Annual Meeting

    Adoption Of New Electronic Medical Records May Inhibit Documentation Of Physician Quality Reporting System

    Minzi Chen, William E. Davis, Austin Fraser, Jerald M. Zakem, Eve Scopelitis, Kismet Collins, MD, Tamika A. Webb-Detiege and Robert Quinet, Rheumatology, Ochsner Medical Center, New Orleans, LA

    Background/Purpose:   Lower back pain (LBP) is a common complaint in the general population and accounts for 2.5% of all outpatient office visits. Critical assessment…
  • Abstract Number: 1918 • 2012 ACR/ARHP Annual Meeting

    Cluster Analysis of Organ Involvements Patients with Serum IgG4 Elevation; IgG4–related Disease Is a Distinct Subtype of Patients with Hyper-IgG4

    Masamitsu Tatewaki, Kazuhiro Kurasawa, Ayae Tanaka, Junya Nagasawa, Satoko Arai, Reika Maezawa, Takayoshi Owada and Takeshi Fukuda, Clinical Immunology, Dokkyo Medical University, Mibu, Tochigi, Japan

    Background/Purpose:   IgG4-related disease (IgG4-RD) is a multi-organ affecting disease characterized by fibroinflammatory lesions with a abundant IgG4-positive plasma cells infiltration. This disorder includes many…
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology